A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)

Status:
Terminated

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects, ages 18 to 65, with generalized anxiety disorder.

Phase 3

Pfizer

Paroxetine